In a very recent NGS study of 464 patients with MF, Coltro et al. provided evidence for an association of mutations in the RAS pathway genes CBL, KRAS, and NRAS with shorter OS and leukemia-free survival [57]. The gene discussed is KRAS; the disease is leukemia.